Novartis CEO: Digitizing medicine
Novartis CEO, Joseph Jimenez, discusses with McKinsey’s Rik Kirkland issues including the emerging need for regenerative medicine, how digitization is driving innovation, and why Novartis is shifting to an outcomes-based approach for patient treatments.
Watch the video or read the transcript here.